Copenhagen, Capital Region of Denmark, Denmark Novo Seeds is the famous VC, which was founded in 2007. The leading representative office of defined VC is situated in the Hellerup. The fund was located in Europe if to be more exact in Denmark.
Among the most popular portfolio startups of the fund, we may highlight Galecto Biotech. Among the most successful fund investment fields, there are Biopharma, Chemical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Denmark. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Novo Seeds, startups are often financed by M Ventures, SEED Capital, Sofinnova Investments. The meaningful sponsors for the fund in investment in the same round are M Ventures, Sofinnova Investments, Lundbeckfonden Emerge. In the next rounds fund is usually obtained by M Ventures, Sunstone Life Science Ventures, Lundbeckfonden Emerge.
Besides them, we counted 5 critical employees of this fund in our database.
The real fund results show that this VC is 18 percentage points more often commits exit comparing to other companies. The higher amount of exits for fund were in 2014. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 deals per year. The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. Comparing to the other companies, this Novo Seeds performs on 22 percentage points less the average number of lead investments.
| Fund Name | Location |
| BaseKit | England, London, United Kingdom |
| Bisque | Mauritius, Moka, Moka |
| Defiance Capital | New York, New York, United States |
| Genuity | - |
| Harbin Gloria Pharmaceuticals | China, Harbin, Heilongjiang |
| Matignon Investissement & Gestion | France, Ile-de-France, Paris |
| Nelson Investments | British Columbia, Canada, Vancouver |
| RBC Ventures | Canada, Ontario, Toronto |
| Shijiazhuang Hongtu Jishen Chuangye Touzi Co., Ltd. | China, Hebei, Shijiazhuang |
| Thompson Taraz Managers | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
NorthSea Therapeutics | $80M | 17 Dec 2021 | The Netherlands, North Holland, Netherlands | ||
Chromologics | $4M | 01 Jun 2021 | Denmark, Capital Region of Denmark, Denmark | ||
Bactolife | $8M | 19 Apr 2021 | Denmark, Capital Region of Denmark, Denmark | ||
Syndesi Therapeutics | $20M | 15 Feb 2018 | Belgium, Limburg, Belgium |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
NorthSea Therapeutics | $80M | 17 Dec 2021 | The Netherlands, North Holland, Netherlands | ||
Chromologics | $4M | 01 Jun 2021 | Denmark, Capital Region of Denmark, Denmark | ||
Bactolife | $8M | 19 Apr 2021 | Denmark, Capital Region of Denmark, Denmark | ||
Syndesi Therapeutics | $20M | 15 Feb 2018 | Belgium, Limburg, Belgium |
